반응식
[CH2:1]=[CH:2][CH:3]=[CH:4][CH3:5].[BrH:6].CC1(C)CNC(NN=C(C=CC2C=CC(Cl)=CC=2)C=CC2C=CC(Cl)=CC=2)=NC1.[N:36]1[CH:40]2CC[CH2:43][CH2:44][CH:39]2[NH:38][C:37]=1[NH:45][N:46]=[C:47]([CH:57]=[CH:58][C:59]1[CH:64]=[CH:63][C:62]([Cl:65])=[CH:61][CH:60]=1)[CH:48]=[CH:49][C:50]1[CH:55]=[CH:54][C:53]([Cl:56])=[CH:52][CH:51]=1>>[BrH:6].[NH:36]1[CH2:40][CH2:39][CH2:44][CH2:43][CH2:5][CH2:4][CH2:3][CH2:2][CH2:1][N:38]=[C:37]1[NH:45][N:46]=[C:47]([CH:48]=[CH:49][C:50]1[CH:51]=[CH:52][C:53]([Cl:56])=[CH:54][CH:55]=1)[CH:57]=[CH:58][C:59]1[CH:64]=[CH:63][C:62]([Cl:65])=[CH:61][CH:60]=1참가 물질
4
반응물 3
생성물 1
실험 절차
The pentadiene in accordance with claim 10, 1,5-bis(p-chlorophenyl)-1,4-pentadiene-3-one 5,5-dimethyl-1,4,5,6-tetrahydropyrimidin-2-ylhydrazone hydrobromide. 13. The pentadiene in accordance with claim 1, 1,5-bis(p-chlorophenyl)-1,4-pentadiene-3-one 3α ,4,5,6,7,7a-hexahydrobenzimidazol-2-yl-hydrazone hydrochloride. 14. The pentadiene in accordance with claim 1, 1,5-bis(p-chlorophenyl)-1,4-pentadien-3-one 3α ,4,5,6,7,7a-hexahydrobenzimidazol-2-yl-hydrazone hydrobromide. 15. The pentadiene in accordance with claim 1, 1,5-bis(p-chlorophenyl)-1,4-pentadiene-3-one 3a,4,5,6,7,7a-hexahydrobenzimidazol-2-yl-hydrazone.
출처 및 근거
- ORD 기록
- ord-bbe8ad376f884048a1e8e9bd91b16fdf
- 출처 데이터셋
- uspto-grants-1977_08
- 특허 번호
- USRE029358
연결된 노트
불러오는 중…